Related Experiment Videos
New antiepileptic therapies
1Department of Neurology Seattle VA Medical Center, Washington, USA.
Clinical Nursing Practice in Epilepsy
|April 1, 1997
Summary
Four new antiepileptic drugs (AEDs) were approved recently, offering new treatment options. Choosing the best AED requires careful consideration of seizure type, drug properties, and interactions.
Area of Science:
- Neurology
- Pharmacology
Background:
- Recent advancements in antiepileptic drug (AED) development.
- Approval of four new AEDs in the past three years.
- Evaluation of several additional AEDs is ongoing.
Purpose of the Study:
- To highlight recent developments in AEDs.
- To inform healthcare providers about new treatment options.
- To guide the selection of appropriate AEDs for patients.
Main Methods:
- Review of newly approved AEDs and formulations.
- Consideration of traditional therapies with new formulations (e.g., Tegretol XR).
- Inclusion of intravenous (IV) and intramuscular (IM) fosphenytoin as alternatives.
Main Results:
- Four new AEDs have been approved for clinical use.
- New formulations of existing drugs offer alternative management strategies.
- Emerging AEDs are under evaluation.
Conclusions:
- The current landscape of AEDs presents expanded choices for managing seizure disorders.
- Selecting the optimal AED necessitates a comprehensive assessment.
- Key factors for selection include seizure type, AED mechanism of action, pharmacokinetics, adverse effects, and drug interactions.